Kindbody Silicon Valley

Outcomes — CDC ART 2022

261 total ART cycles reported.

Cumulative success rate for patients using their own eggs (with or without prior ART cycles). Estimated retrievals = 1 / live birth rate (independence assumption — real-world outcomes vary with embryo banking and protocol changes). Source: CDC NASS ART Summary (2022).

Clinic information

Address

4756 El Camino Real, Los Altos 94022

Phone

(650) 445-4724

CDC Clinic ID

870

Status

Open

Source: CDC National ART Surveillance System (NASS) Final ART Summary 2022.

Published pricing

Kindbody Silicon Valley does not publish itemized IVF pricing on its public website. Pricing is typically disclosed by a financial counselor after consultation. Typical US clinic range: $14,000–$30,000 per cycle plus medication.Kindbody maintains a public pricing page at kindbody.com/services-pricing/ and explicitly offers financing (via PatientFi), but search engine crawls of that page did not surface any specific dollar amounts for IVF, egg freezing, FET, ICSI, PGT, or storage — only medication cost approximations and a disclaimer that prices vary by clinic location. All itemized figures found in search results originated from third-party sites and were excluded per schema rules; a direct browser visit to the pricing page would be required to extract confirmed figures.Financing options offered.

Cycle characteristics

Retrievals with no eggs collected

3.5%

Cycles discontinued before transfer

4.3%

Cycles for fertility preservation

52.9%

Transfers using a gestational carrier

7.5%

Frozen embryo transfers

100.0%

Transfers using ICSI

96.2%

Transfers using PGT

86.8%

Services offered

• ✓ Donor egg services
• ✓ Gestational carrier services
• ✓ Egg cryopreservation
• ✓ Embryo cryopreservation
• ✓ SART member clinic

Patient infertility causes (CDC reported)

Causes can overlap — patients may report more than one. Percentages do not sum to 100%.

Other (infertility)

13%

Unexplained

10%

Male factor

8%

Diminished ovarian reserve

6%

Endometriosis

5%

Tubal factor

4%

Uterine factor

3%

Other (non-infertility)

3%

Ovulatory dysfunction

2%

Recurrent pregnancy loss

1%